首页工具

登录

搜索结果

Search Results for " imatinib "

33

抑制剂 & 化合物

1

天然产物

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T6230	Imatinib 伊马替尼,STI571,CGP057148B,ST-1571	SARS-CoV; Bcr-Abl; PDGFR; c-Kit; Autophagy	Angiogenesis; Autophagy; Cytoskeletal Signaling; Microbiology/Virology; Tyrosine Kinase/Adaptors
	Imatinib (STI571) 是一种多靶点受体酪氨酸激酶抑制剂，可选择性抑制 BCR/ABL、v-Abl、PDGFR、c-kit 等激酶活性，具有口服活性。Imatinib 具有抗肿瘤活性，可用于治疗慢性粒细胞白血病。
T11641	N-Desmethyl imatinib Imatinib metabolite N-Desmethyl imatinib,Norimatinib,N-去甲基伊马替尼	Bcr-Abl; PDGFR; c-Kit; Drug Metabolite	Angiogenesis; Cytoskeletal Signaling; Metabolism; Tyrosine Kinase/Adaptors
	N-Desmethyl imatinib (Imatinib metabolite N-Desmethyl imatinib) 是 Imatinib 的代谢物。Imatinib 是一个靶向 c-Kit、v-Abl 和 PDGFR 的多靶点抑制剂。
T1621	Imatinib Mesylate 甲磺酸伊马替尼,ST-1571 Mesylate,STI-571,CGP-57148B	Bcr-Abl; PDGFR; c-Kit; Autophagy	Angiogenesis; Autophagy; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors
	Imatinib Mesylate (STI-571) 是一种酪氨酸激酶受体抑制剂，具有抗肿瘤活性，对 v-Abl、c-Kit 和 PDGFR 的 IC50 分别为 0.6 μM、0.1 μM 和 0.1 μM。
T67847	Imatinib impurities3	Bcr-Abl; PDGFR; c-Kit	Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors
	Imatinib impurities3是一种蛋白激酶抑制剂，对 ABL1 wt、KIT wt 和 PDGFRR wt 的 IC50值分别为6.95μM 、0.245μM 和0.139μM 。
T40504	N-Desmethyl imatinib mesylate ImatinibmetaboliteN-Desmethylimatinibmesylate,N-Desmethyl imatinib mesylate,Norimatinib mesylate
	Norimatinib mesylate, also known as N-Desmethyl imatinib mesylate, is a metabolite derived from Imatinib, which acts as a potent multi-target inhibitor of v-Abl, c-Kit, and PDGFR.
T19451	N-Desmethyl imatinib-d8 Norimatinib D8,Imatinib metabolite N-Desmethyl imatinib D8,N-Desmethyl imatinib D8	Others	Others
	N-Desmethyl imatinib D8 is a deuterium labeled Imatinib metabolite N-Desmethyl Imatinib.
T22859	Imatinib hydrochloride	Others	Others
	Imatinib is a multi-target inhibitor of v-Abl, c-Kit, and PDGFR (IC50: 0.6 μM, 0.1 μM, and 0.1 μM, respectively). Imatinib is used to treat chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs), and a number of other malignancies.
T19015	Imatinib Acid	Others	Others
	Imatinib Acid is usually used as a fluorescent probe or labeled chemical.
T11639	Imatinib D4 CGP-57148B D4,STI571 D4	Others	Others
	Imatinib D4 is a deuterium-labeled Imatinib. Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, PDGFR, v-Abl, and c-kit kinase activity.
T11640	Imatinib-d8 CGP-57148B D8,STI571 D8	Others	Others
	Imatinib D8 is a deuterium-labeled Imatinib. Imatinib is an orally bioavailable tyrosine kinases inhibitor that inhibits BCR/ABL, PDGFR, v-Abl, and c-kit kinase activity.
T18592	Imatinib carbaldehyde CGP-57148B carbaldehyde,STI571 carbaldehyde,PROTAC ABL binding moiety 1	Others	Others
	Imatinib carbaldehyde (also known as CGP-57148B carbaldehyde) is a compound derived from Imatinib, an inhibitor of the ABL protein. Imatinib carbaldehyde binds to the IAP ligand with the assistance of a linker, resulting in the formation of SNIPER[1].
T73973	Imatinib Impurity E
	Imatinib Impurity E 是 Imatinib 的杂质。Imatinib 是一种口服生物可用的酪氨酸激酶抑制剂，可选择性抑制 BCR/ABL，v-Abl，PDGFR，c-kit 激酶活性。Imatinib (STI571) 靠近 ATP 结合位点结合，将其锁定在封闭或自我抑制的构象中，因此半竞争性抑制蛋白质的酶活性。Imatinib 还抑制 SARS-CoV 和MERS-CoV。
T64338	AKI603 AKI 603,AKI-603	Aurora Kinase	Cell Cycle/Checkpoint; Chromatin/Epigenetic
	AKI603 是一种极光激酶 A 抑制剂，IC50值为 12.3 nM。它对白血病细胞具有很强的抗增殖活性，可用于克服白血病中 BCR-ABL-T315I 耐药性突变。
T3071	Olverembatinib GZD 824	Bcr-Abl	Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors
	Olverembatinib (GZD 824) 是一种高效的、口服具有活性的pan-Bcr-Abl 抑制剂，具有抗肿瘤活性。它能广泛而有效地抑制突变型 Bcr-Abl。它对天然的 Bcr-Abl 和 Bcr-AblT315I 作用的IC50值分别为 0.34 nM 和 0.68 nM。
T2429	Olverembatinib dimesylate GZD824 Dimesylate,HQP1351	Bcr-Abl	Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors
	Olverembatinib dimesylate (GZD824 Dimesylate) 是一种高效的、口服具有活性的pan-Bcr-Abl 抑制剂，具有抗肿瘤活性。它能广泛而有效地抑制突变型 Bcr-Abl。它对天然的 Bcr-Abl 和 Bcr-AblT315I 作用的IC50值分别为 0.34 nM 和 0.68 nM。
T1448L	Dasatinib monohydrate 达沙替尼,BMS-354825 Monohydrate	Apoptosis; Bcr-Abl; Src; c-Kit; Ephrin Receptor; Autophagy	Angiogenesis; Apoptosis; Autophagy; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors
	Dasatinib monohydrate (BMS-354825 Monohydrate) 是一种具有口服活性的，ATP 竞争性的双重Src/Bcr-Abl 抑制剂，有抗肿瘤活性，还诱导凋亡和自噬。它抑制Src 和Bcr-Abl 的IC50分别为 0.5 nM 和 <1.0 nM，Ki 值分别为 16 pM 和 30 pM。
T27555	HS-438 HS 438
	HS-438 inhibits imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.
T24496	MPT0B002 MPT-0-B-002,MPT 0 B 002
	MPT0B002 is a microtubule inhibitor that acts by downregulating T315I mutant Bcr-Abl and inducing apoptosis of imatinib-resistant chronic myeloid leukemia cells.
T69045	ON012380
	ON012380 is a non-ATP-competitive Bcr-Abl inhibitor, potently inhibiting imatinib-resistant Bcr-Abl mutants such as T315I.
T23617	Aclacinomycin Aclacinomycins,Siwenmycin
	Aclacinomycin A is an anthracycline drug. It sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation. It is used in the treatment of cancer.
T18693	SNIPER(ABL)-049	Others	Others
	SNIPER(ABL)-049, conjugating Imatinib (ABL inhibitor) to Bestatin (IAP ligand) with a linker, induces the reduction of BCR-ABL protein with a DC50 of 100 μM[1].
T71144	Nilotinib N-oxide
	Nilotinib N-oxide is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia.
T68581	AP23464
	AP23464 is a potent adenosine 5'-triphosphate (ATP)-based inhibitor of Src and Abl kinases, displays antiproliferative activity against a human CML cell line and Bcr-Abl-transduced Ba/F3 cells (IC(50) = 14 nM. AP23464 ablates Bcr-Abl tyrosine phosphorylation, blocks cell cycle progression, and promotes apoptosis of Bcr-Abl-expressing cells. Biochemical assays with purified glutathione S transferase (GST)-Abl kinase domain confirmed that AP23464 directly inhibits Abl activity. Importantly, the lo...
T68338	Nilotinib hydrochloride dihydrate
	Nilotinib hydrochloride dihydrate is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia.
T71068	Nilotinib dihydrochloride dihydrate
	Nilotinib dihydrochloride dihydrate is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia.
T18694	SNIPER(ABL)-050	Others	Others
	SNIPER(ABL)-050 is a chemical compound that combines Imatinib, an ABL inhibitor, with MV-1, an IAP ligand, using a linker. This conjugation results in the reduction of BCR-ABL protein[1].
T18695	SNIPER(ABL)-058	Others	Others
	SNIPER(ABL)-058, conjugating Imatinib (ABL inhibitor) to LCL161 derivative (IAP ligand) with a linker, induces the reduction of BCR-ABL protein with a DC50 of 10 μM[1].
T61731	PPARγ agonist 4
	PPARγ agonist 4 (Compound 18b), a potent and selective PPARγ agonist, demonstrates antitumor efficacy only when used in conjunction with Imatinib. Notably, PPARγ agonist 4 does not exhibit cytotoxic effects on either non-resistant or resistant cells [1].
T61465	PPARγ agonist 3
	PPARγ agonist 3, also known as Compound 18a, is a potent and selective agonist of PPARγ. This compound does not exhibit cytotoxicity towards both non-resistant and resistant cells. Notably, PPARγ agonist 3 demonstrates antitumor efficacy exclusively when co-administered with Imatinib [1].
T69296	PHA-680626
	PHA-680626 is a potent and selective PLK inhibitor. PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases. PHA-680626 inhibits Plk1 (IC50 = 0.53 μM), Plk2 (IC50 = 0.07 μM) and Plk3 (IC50 = 1.61 μM).
T63450	BCR-ABL-IN-6
	BCR-ABL-IN-6 (9h) 是一种伊马替尼衍生物，也是 Bcr-Abl 激酶的选择性抑制剂，能够作用于 Bcr-AblWT (IC50: 4.6 nM) 和 Bcr-AblT3151 (IC50: 277 nM)。BCR-ABL-IN-6 (9h)对 Bcr-Abl 激酶具有较强的细胞内亲和力 (EC50: 14.6 nM)。BCR-ABL-IN-6 (9h) 能够用于研究慢性髓细胞性白血病治疗。
T79711	Antitumor photosensitizer-4	Apoptosis	Apoptosis
	Antitumor photosensitizer-4 (compound 10b) 是靶向ABCG2酪氨酸激酶抑制剂(TKI)的有效代表，由达沙替尼与伊马替尼构成的光敏剂(PS)。该化合物能够诱发细胞凋亡(apoptosis)及ROS生成，在HepG2和B16-F10细胞上展现出显著的光毒性作用。
T71654	APcK110
	APcK110 is a novel Kit inhibitor . APcK110 inhibits proliferation of the mastocytosis cell line HMC1.2 and the SCF-responsive cell line OCI/AML3 in a dose-dependent manner . APcK110 is a more potent inhibitor of OCI/AML3 proliferation than the clinically used Kit inhibitors imatinib and dasatinib and at least as potent as cytarabine. APcK110 inhibits the phosphorylation of Kit, Stat3, Stat5, and Akt in a dose-dependent fashion, showing activity of APcK110 on Kit and its downstream signaling path...

化合物

Cat.No: T6230

Synonym: 伊马替尼,STI571,CGP057148B,ST-1571

Target: SARS-CoV, Bcr-Abl, PDGFR, c-Kit, Autophagy

N-Desmethyl imatinib

Cat.No: T11641

Synonym: Imatinib metabolite N-Desmethyl imatinib,Norimatinib,N-去甲基伊马替尼

Target: Bcr-Abl, PDGFR, c-Kit, Drug Metabolite

Imatinib Mesylate

Cat.No: T1621

Synonym: 甲磺酸伊马替尼,ST-1571 Mesylate,STI-571,CGP-57148B

Target: Bcr-Abl, PDGFR, c-Kit, Autophagy

Imatinib impurities3

Cat.No: T67847

Target: Bcr-Abl, PDGFR, c-Kit

N-Desmethyl imatinib mesylate

Cat.No: T40504

Synonym: ImatinibmetaboliteN-Desmethylimatinibmesylate,N-Desmethyl imatinib mesylate,Norimatinib mesylate

N-Desmethyl imatinib-d8

Cat.No: T19451

Synonym: Norimatinib D8,Imatinib metabolite N-Desmethyl imatinib D8,N-Desmethyl imatinib D8

Target: Others

Imatinib hydrochloride

Cat.No: T22859

Target: Others

Imatinib Acid

Cat.No: T19015

Target: Others

Cat.No: T11639

Synonym: CGP-57148B D4,STI571 D4

Target: Others

Cat.No: T11640

Synonym: CGP-57148B D8,STI571 D8

Target: Others

Imatinib carbaldehyde

Cat.No: T18592

Synonym: CGP-57148B carbaldehyde,STI571 carbaldehyde,PROTAC ABL binding moiety 1

Target: Others

Imatinib Impurity E

Cat.No: T73973

Cat.No: T64338

Synonym: AKI 603,AKI-603

Target: Aurora Kinase

Cat.No: T3071

Synonym: GZD 824

Target: Bcr-Abl

Olverembatinib dimesylate

Cat.No: T2429

Synonym: GZD824 Dimesylate,HQP1351

Target: Bcr-Abl

Dasatinib monohydrate

Cat.No: T1448L

Synonym: 达沙替尼,BMS-354825 Monohydrate

Target: Apoptosis, Bcr-Abl, Src, c-Kit, Ephrin Receptor, Autophagy

Cat.No: T27555

Synonym: HS 438

Cat.No: T24496

Synonym: MPT-0-B-002,MPT 0 B 002

Cat.No: T69045

Cat.No: T23617

Synonym: Aclacinomycins,Siwenmycin

SNIPER(ABL)-049

Cat.No: T18693

Target: Others

Nilotinib N-oxide

Cat.No: T71144

Cat.No: T68581

Nilotinib hydrochloride dihydrate

Cat.No: T68338

Nilotinib dihydrochloride dihydrate

Cat.No: T71068

SNIPER(ABL)-050

Cat.No: T18694

Target: Others

SNIPER(ABL)-058

Cat.No: T18695

Target: Others

PPARγ agonist 4

Cat.No: T61731

PPARγ agonist 3

Cat.No: T61465

Cat.No: T69296

Cat.No: T63450

Antitumor photosensitizer-4

Cat.No: T79711

Target: Apoptosis

Cat.No: T71654

Cat. No.	Product Name	Target	Signaling Pathways
TN4404	Ladanein	HCV Protease	Microbiology/Virology; Proteases/Proteasome
	Ladanein is a phytochemicals inhibitor that is known to disrupt the interactions of core and other hepatitis C virus (HCV) proteins.Ladanein possesses free radicals DPPH and ABTS +.scavenging activity, it also displays moderate (20-40 microM) activities against K562, K562R (imatinib-resistant), and 697 human leukemia cell lines.

天然产物

Cat.No: TN4404

Target: HCV Protease

我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

Copyright © 2015-2024 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4

沪公网安备 31010602006700号

沪公网安备 31010602006700号

TargetMol Loading

联系我们

电话：

400-820-0310

邮箱：

service@tsbiochem.com

QQ：

2881945090（终端用户）

2885109491（经销商）

经销：

终端：

地址：

上海市静安区江场三路238号8楼